[18F]ML-10 PET imaging fails to assess early response to neoadjuvant chemotherapy in a preclinical model of triple negative breast cancer

[18F]ML-10 PET imaging fails to assess early response to neoadjuvant chemotherapy in a preclinical model of triple negative breast cancer

Abstract Purpose Pathological complete response to the neoadjuvant therapy (NAT) for triple negative breast cancer (TNBC) is predictive of prolonged patient survival. Methods for early evaluation of NAT efficiency are still needed, in order to rapidly adjust the therapeutic strategy in case of initi...

Full description

Bibliographic Details
Main Authors: Elodie Jouberton, Sébastien Schmitt, Emmanuel Chautard, Aurélie Maisonial-Besset, Marie Roy, Nina Radosevic-Robin, Jean-Michel Chezal, Elisabeth Miot-Noirault, Yann Bouvet, Florent Cachin
Format: Article
Language:English
Published: SpringerOpen 2020-01-01
Series:EJNMMI Research
Subjects:
[18F]ML-10
apoptosis
PET imaging
triple negative breast cancer
in vivo
chemotherapy
Online Access:https://doi.org/10.1186/s13550-019-0587-5

Internet

https://doi.org/10.1186/s13550-019-0587-5

Similar Items